MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

Distalmotion

Corporate marketmedicalCurated record
distalmotion.com

DEXTER is a surgeon-controlled laparoscopic robotic surgery system; fully wristed single-use instruments provide enhanced dexterity for minimally invasive procedures (hernia, cholecystectomy, gynecology, urology). Open-system architecture integrates with third-party imaging and OR equipment. AI-assisted instrument tracking aids surgeon; system augments rather than replaces surgeon control; not fully autonomous. Designed for ambulatory surgery centers and hospital outpatient settings.

HeadquartersEpalinges, CH
Founded2012
Corporate funding$390M
Team201-500
Deployments6
Open roles11
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries G
FoundersRicardo Beira (Co-Founder), Lionel Flaction (Co-Founder)
Regions servedEurope, North America
Countries deployedCH, US, DE, FR
Service footprintRobotic surgery system (DEXTER) sold CapEx to hospitals and ambulatory surgery centers; US focus on ASC outpatient market (hernia, cholecystectomy, hysterectomy, gynecology); European commercial operations ongoing; HQ in Epalinges (Lausanne area), Switzer
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

DEXTER Robotic Surgery System

  • Small, mobile footprint; integrates into any OR size without modifications; docking time approximately 4 minutes

    vendor-defined setup time and footprint

    Claim source
  • Fully wristed single-use instruments; surgeon can switch between laparoscopic and robotic technique without redocking

    vendor-defined instrument design and technique flexibility

    Claim source
  • FDA-cleared US indications (as of June 2026): laparoscopic inguinal hernia repair, cholecystectomy, total benign hysterectomy, and expanded gynecology indications

    regulatory clearances; 510(k) FDA approvals for indicated procedures

    Claim source
  • Over 3,000 patients treated across Europe and the US as of Q4 2025

    vendor-stated cumulative clinical use milestone

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-05-21CommonSpirit Healthambulatory surgery center / robotic surgeryUSNot disclosedAnnouncement
2026-05-21HonorHealthambulatory surgery center / robotic surgeryUSNot disclosedAnnouncement
2026-05-21Surgery Partnersambulatory surgery center / robotic surgeryUSNot disclosedAnnouncement
2025-06-24AdventHealthhospital network, ambulatory surgery centers and outpatient surgical facilitiesUSNot disclosedAnnouncement
2025-03-27Northtowns Ambulatory Surgery Center (Kaleida Health joint venture, Buffalo NY)ambulatory surgery center, first US ASC acquisition of DEXTERUS1Announcement
2025-03-25Memorial Hermann Health Systemhospital surgery centerUSNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordRevival Healthcare Capital415 CapitalJohnson & Johnson JJDCHelvetica CapitalNuman Wealth PartnersSwiss Entrepreneurs FoundationKinled HoldingBlueOcean Ventures
HR

Hiring signal

Public job board · 2026-07-13

Open roles11

Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.

Clinical Sales SpecialistCommercial, Europe · Lausanne, SwitzerlandArea Sales Manager, Mountain TerritoryCommercial, US · Denver, United StatesArea Sales Manager, Northwest TerritoryCommercial, US · San Francisco, United StatesArea Sales Manager, Southeast TerritoryCommercial, US · Nashville, United StatesAssociate Director, Strategic Accounts - North-Central and Northeast USCommercial, US · United StatesClinical Sales Specialist (USA)Commercial, US · Indianapolis, United StatesSr. Commercial Systems Analyst (Central Or Eastern time zone)Commercial, US · United StatesClinical Training Specialist - EuropeGlobal Marketing · Épalinges, Switzerland
TL

Company timeline

Milestones and announcements

2026-06-16FDA 510(k) clearance for expanded gynecology indications enabling ASC GYN service line expansionDistalmotion
2026-01-13Strategic investment from J&J Innovation (JJDC) to advance ASC expansion of DEXTERDistalmotion
2025-11-18$150M Series G closed (Revival Healthcare Capital lead); Chas McKhann named Executive ChairmanGlobeNewswire
2025-06-24AdventHealth (50-hospital US network) acquires multiple DEXTER systems: first multi-robot US saleGlobeNewswire
2025-03-25First US sale of DEXTER to Memorial Hermann Health SystemGlobeNewswire
SC

Source ledger

15 unique public sources

01
Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER Robotic Surgery SystemDistalmotion · retrieved 2026-07-05
02
Distalmotion Raises $150 Million to Accelerate US Expansion of the DEXTER Robotic Surgery SystemGlobeNewswire · retrieved 2026-07-05
03
Swiss medical device company Distalmotion bags €136.9M to bring its surgical robot to the USSilicon Canals · retrieved 2026-07-05
04
Swiss-based Distalmotion raises €80.65M to remove the complexity out of robotic surgerySilicon Canals · retrieved 2026-07-05
05
DEXTER Robotic Surgery SystemDistalmotion · retrieved 2026-07-05
06
Distalmotion NewsDistalmotion · retrieved 2026-07-05
07
Distalmotion Raises $150 MillionDistalmotion · retrieved 2026-07-05
08
Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery CentersGlobeNewswire · retrieved 2026-07-05
09
Distalmotion Achieves Milestone as AdventHealth Acquires Multiple DEXTER Robotic Surgery SystemsGlobeNewswire · retrieved 2026-07-05
10
Distalmotion Announces Acquisition of DEXTER by First Ambulatory Surgery Center in the USGlobeNewswire · retrieved 2026-07-05
11
Distalmotion Completes First US Sale of its DEXTER Robotic Surgery System to Memorial Hermann Health SystemGlobeNewswire · retrieved 2026-07-05
12
DEXTER® Robotic Surgery SystemSAGES · retrieved 2026-07-05
13
Distalmotion Gains FDA 510(k) Clearance for CholecystectomyDistalmotion · retrieved 2026-07-05
14
Distalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology IndicationsDistalmotion · retrieved 2026-07-05
15
· retrieved 2026-07-05